Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 18/20 | 0.78 |
| ▸ | FNTB | P49356 | 16/20 | 0.78 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1759376 | 1.00 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL34468137 | 1.00 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL28408955 | 1.00 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL30009312 | 1.00 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| SCHEMBL335749 | 0.98 | FNTA (0.75) | FNTAFNTBPGGT1B | |
| SCHEMBL335748 | 0.98 | FNTA (0.75) | FNTAFNTBPGGT1B | |
| Ammonia Solution, Strong SCHEMBL27786620 | 0.97 | FNTA (0.73) | FNTAFNTBPGGT1B | |
| SCHEMBL26668880 | 0.97 | FNTA (0.78) | FNTAFNTBPGGT1B | |
| Ammonia Solution, Strong SCHEMBL27786619 | 0.97 | FNTA (0.73) | FNTAFNTBPGGT1B | |
| Farnesyl Diphosphate SCHEMBL25390280 | 0.94 | FNTA (0.89) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110317765-A | A kind of E. coli expression strains of high yield geraniol glucoside and its application | 中国科学院天津工业生物技术研究所 | 2019-10-11 | — | — | CN | claimed |
| WO-2025041718-A1 | COMPOUND HAVING ANTI-ENTAMOEBA HISTOLYTICA ACTIVITY | 国立大学法人東海国立大学機構 | 2025-02-27 | — | — | WO | disclosed |
| US-20240058310-A1 | METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH CALCIUM ION SIGNALING | UNIV TEMPLE (US) | 2024-02-22 | — | — | US | disclosed |
| CN-109874293-A | Small molecule therapeutic compounds that reduce the incidence of intracerebral hemorrhage and cerebral microhemorrhage | 斑马药研公司 | 2019-06-11 | — | — | CN | disclosed |
| CN-109207477-A | Novel C RISPR enzyme and system | 布罗德研究所有限公司 | 2019-01-15 | — | — | CN | disclosed |
| CN-108513582-A | NOVEL CRISPR ENZYMES AND SYSTEMS | 布罗德研究所有限公司 | 2018-09-07 | — | — | CN | disclosed |
| CN-107949279-A | It can be used as the benzamide or benzamine compound of the anticancer for treating human cancer | 得克萨斯系统大学评议会 | 2018-04-20 | — | — | CN | disclosed |
| CN-107206009-A | Compositions and methods for treating visual disorders | 广州康睿生物医药科技股份有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-103649309-A | Valencene synthase | ISOBIONICS B V | 2014-03-19 | — | — | CN | disclosed |
| CN-101889089-B | Transgenic plants with increased stress tolerance and yield | BASF PLANT SCIENCE GMBH | 2013-10-23 | — | — | CN | disclosed |
| CN-101432427-A | Method for identifying useful proteins of brewery yeast | SUNTORY LTD (JP) | 2009-05-13 | — | — | CN | disclosed |
| EP-2010910-A2 | DIFFERENTIAL EXPRESSION PROFILING ANALYSIS OF CELL CULTURE PHENOTYPES AND THE USES THEREOF | Wyeth (US) | 2009-01-07 | — | — | EP | disclosed |
| US-7469185-B2 | Primary rat hepatocyte toxicity modeling | OCIMUM BIOSOLUTIONS, INC. (US) | 2008-12-23 | — | — | US | disclosed |
| CN-101301298-A | Hyperlipemia prophylactic and therapeutic agent | XINGHUI TIANLI HANGZHOU PHARMA (CN) | 2008-11-12 | — | — | CN | disclosed |
| WO-2008054514-A2 | DIFFERENTIAL EXPRESSION PROFILING ANALYSIS OF CELL CULTURE PHENOTYPES AND THE USES THEREOF | WYETH (US) | 2008-05-08 | — | — | WO | disclosed |
| US-20080070268-A1 | Differential expression profiling analysis of cell culture phenotypes and the uses thereof | WYETH (US) | 2008-03-20 | — | — | US | disclosed |
| EP-1545220-A1 | ATTRACTANT FOR APPLE FRUIT MOTH AND OTHER INSECT PESTS OF APPLE | Forskarpatent i Syd AB (SE) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004028256-A1 | ATTRACTANT FOR APPLE FRUIT MOTH AND OTHER INSECT PESTS OF APPLE | FORSKARPATENT I SYD AB (SE) | 2004-04-08 | — | — | WO | disclosed |
| CN-1101392-C | Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives | JANSSEN PHARMACEUTICA NV (BE) | 2003-02-12 | — | — | CN | disclosed |
| CN-1203598-A | Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives | JANSSEN PHARMACEUTICA NV (BE) | 1998-12-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070268-A1 | Differential expression profiling analysis of cell culture phenotypes and the uses thereof | ANKRD52, PPP4R3A, PPP6R3 | FNTA 2341/4885FNTB 2368/4885PGGT1B 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.